Verified publication
Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice.
Verified PubMed record for SS-31: Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice.
PubMed metadata verifiedQuality: Not assessedLow confidence
Study metadata
- Journal
- Journal of neuroinflammation
- Publication year
- 2019
- Study type
- Animal study
- Species
- Mouse
- Evidence grade
- Grade C
- Extraction depth
- PubMed metadata verified
- Study quality
- Not assessed
- Confidence
- Low confidence
- Sample size
- Not stated in indexed abstract
Structured extraction
- Population
- Mouse model; strain and model details require article-level extraction.
- Intervention
- Animal-model exposure details require abstract or full-text extraction before use.
- Comparator
- Not extracted from PubMed metadata.
- Duration
- Not extracted from PubMed metadata.
- Primary endpoint
- Primary animal-model endpoint not fully extracted.
- Secondary endpoints
- No secondary endpoints extracted.
- Funding source
- Not extracted from PubMed metadata.
Findings and extraction notes
- PubMed indexes this publication under PMID 31747905; Atlas verified title, journal, year, and DOI metadata where available before publishing the page.
- The record is linked to SS-31 for literature mapping, but Atlas has not promoted the indexed metadata into a mechanistic or clinical outcome claim.
Limitations
- Phase 3 metadata verification confirms citation identity; it does not replace full independent extraction of methods, endpoints, or effect sizes.
- Interpretation should remain limited to the publication type, species context, and verified PubMed metadata shown on this page.